These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23365425)

  • 1. Structural analysis of the evolutionary origins of influenza virus hemagglutinin and other viral lectins.
    Chen L; Li F
    J Virol; 2013 Apr; 87(7):4118-20. PubMed ID: 23365425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution.
    Zeng Q; Langereis MA; van Vliet AL; Huizinga EG; de Groot RJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9065-9. PubMed ID: 18550812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host mediated variation and receptor binding specificity of influenza viruses.
    Suzuki Y
    Adv Exp Med Biol; 2001; 491():445-51. PubMed ID: 14533814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variation of influenza viruses and their recognition of the receptor sialo-sugar chains].
    Suzuki Y
    Yakugaku Zasshi; 1993 Aug; 113(8):556-78. PubMed ID: 7690853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of biological activities of influenza virus hemagglutinin by its carbohydrate moiety.
    Ohuchi M; Ohuchi R; Matsumoto A
    Microbiol Immunol; 1999; 43(12):1071-6. PubMed ID: 10656174
    [No Abstract]   [Full Text] [Related]  

  • 6. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.
    Dormitzer PR; Sun ZY; Wagner G; Harrison SC
    EMBO J; 2002 Mar; 21(5):885-97. PubMed ID: 11867517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity.
    Couceiro JN; Paulson JC; Baum LG
    Virus Res; 1993 Aug; 29(2):155-65. PubMed ID: 8212857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.
    Bean WJ; Schell M; Katz J; Kawaoka Y; Naeve C; Gorman O; Webster RG
    J Virol; 1992 Feb; 66(2):1129-38. PubMed ID: 1731092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How influenza virus is locked out of the cell.
    Modis Y
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18647-8. PubMed ID: 19033206
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins.
    Nakada S; Creager RS; Krystal M; Aaronson RP; Palese P
    J Virol; 1984 Apr; 50(1):118-24. PubMed ID: 6699942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure.
    DuBois RM; Aguilar-Yañez JM; Mendoza-Ochoa GI; Oropeza-Almazán Y; Schultz-Cherry S; Alvarez MM; White SW; Russell CJ
    J Virol; 2011 Jan; 85(2):865-72. PubMed ID: 21068239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains.
    Suzuki Y
    Prog Lipid Res; 1994; 33(4):429-57. PubMed ID: 7870741
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutinin Inhibitors are Potential Future Anti-Influenza Drugs for Mono- and Combination Therapies.
    Sriwilaijaroen N; Suzuki Y
    Methods Mol Biol; 2020; 2132():547-565. PubMed ID: 32306356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the measles virus hemagglutinin.
    Colf LA; Juo ZS; Garcia KC
    Nat Struct Mol Biol; 2007 Dec; 14(12):1227-8. PubMed ID: 18026116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
    Stern LJ; Brown JH; Jardetzky TS; Gorga JC; Urban RG; Strominger JL; Wiley DC
    Nature; 1994 Mar; 368(6468):215-21. PubMed ID: 8145819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin.
    Hartley CA; Jackson DC; Anders EM
    J Virol; 1992 Jul; 66(7):4358-63. PubMed ID: 1602549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.
    Laver WG
    Adv Exp Med Biol; 1985; 185():149-74. PubMed ID: 3907308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Software for Characterizing the Antigenic and Genetic Evolution of Human Influenza Viruses.
    Reimering S; McHardy AC
    Methods Mol Biol; 2018; 1836():551-565. PubMed ID: 30151591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.